OAU — Des-Gamma-Carboxy-Prothrombin (Dcp), Risk Assessment, Hepatocellular Carcinoma Class II

FDA Device Classification

Classification Details

Product Code
OAU
Device Class
Class II
Regulation Number
866.6030
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

The test is intended to quantitatively measure dcp in human serum and use as an aid in the risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma (hcc) in conjunction with other laboratory findings, imaging studies and clinical assessment for risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K062368wako chemicals usaWAKO LBA DCP TEST SYSTEM, MODEL 993-05301; DCP CONTROL SET, MODEL 995-0551; DCP January 31, 2007